The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal challenge in the high court in London, a UK media report said on......
Eminent British-Indian Cardiologist Dr Aseem Malhotra, who has been leading international calls for the suspension of mRNA COVID-19 vaccines, said on Tuesday that Oxford-AstraZeneca's jab,......
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered......
'We seem to be in a situation where we can do little, and nothing needs to be done anyway.' Photograph: ANI Photo As India's COVID-19 daily case count dips below the 100-mark, approvals for......
Chief Executive Officer of Serum Institute of India, Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021, and of the total......
Amid reports of the ongoing coal shortage in the country, Finance Minister Nirmala Sitharaman stressed that there is no shortage and termed these as “absolutely baseless”, saying India......
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive, reports Sohini Das/Business Standard. IMAGE: A beneficiary......